Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
65.10
+0.05 (0.08%)
Oct 7, 2024, 4:00 PM EDT - Market closed
Utah Medical Products Revenue
Utah Medical Products had revenue of $10.40M in the quarter ending June 30, 2024, a decrease of -19.17%. This brings the company's revenue in the last twelve months to $46.58M, down -10.28% year-over-year. In the year 2023, Utah Medical Products had annual revenue of $50.22M, down -3.93%.
Revenue (ttm)
$46.58M
Revenue Growth
-10.28%
P/S Ratio
5.04
Revenue / Employee
$245,147
Employees
190
Market Cap
226.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 50.22M | -2.06M | -3.93% |
Dec 31, 2022 | 52.28M | 3.23M | 6.58% |
Dec 31, 2021 | 49.05M | 6.88M | 16.30% |
Dec 31, 2020 | 42.18M | -4.73M | -10.08% |
Dec 31, 2019 | 46.90M | 4.91M | 11.68% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fulcrum Therapeutics | 81.63M |
SOPHiA GENETICS | 64.94M |
Codexis | 60.89M |
MacroGenics | 41.02M |
Zentalis Pharmaceuticals | 40.56M |
Sera Prognostics | 107.00K |
UTMD News
- 2 months ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 2 months ago - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024 - Accesswire
- 5 months ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024 - Accesswire
- 8 months ago - UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance - GlobeNewsWire
- 1 year ago - Utah Medical Products, Inc. Increases Regular Quarterly Dividend - Accesswire
- 1 year ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023 - GlobeNewsWire
- 1 year ago - Utah Medical Products: Long-Term Positives, But Filshie Clip Overhang Can't Be Ignored - Seeking Alpha
- 1 year ago - UTMD Updates Status of Filshie Product Liability Lawsuits in the U.S. - Accesswire